TCL1

TCL1 is a selective non-covalent inhibitor targeting the Pru domain of the Rpn-13 subunit in the 19S regulatory particle (19S RP) of the proteasome with an IC50 value of approximately 26 μM. TCL1 interferes with the recognition and transport of ubiquitinated proteins by Rpn-13, inhibits the degradation of proteins by the proteasome, and thus affects the balance of intracellular protein metabolism. TCL1 is promising for research of hematological malignancies[1][2][3].

Product Specifications

UNSPSC

12352005

Target

Proteasome

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cancer

Smiles

O=C(CC1SC2=NN=C(CC3=CC=C(C=C3)Br)N2N=C1C4=CC=C(Cl)C=C4)O

Molecular Formula

C19H14BrClN4O2S

Molecular Weight

477.76

References & Citations

[1]Loy CA, et al. ByeTAC: Bypassing E-Ligase-Targeting Chimeras for Direct Proteasome Degradation. J Med Chem. 2025 May 8;68 (9) :9694-9705.|[2]Winton VJ, et al. Deleterious Consequences of UDP-Galactopyranose Mutase Inhibition for Nematodes. ACS Chem Biol. 2017 Sep 15;12 (9) :2354-2361.|[3]Loy CA, et al. Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers. Bioorg Med Chem Lett. 2023 Oct 15;95:129485.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-159808/

Scientific Category

Reference compound1

Clinical Information

No Development Reported

CAS Number

[875165-39-2]

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

25506176 3 x 5 nmol

Khdrbs2 siRNA Oligos set (Rat)

Ask

View Details

E2619930 100 µL

TC10 (Center) Rabbit pAb

Ask